The psoriasis supplement trials keep disappointing, and the design is why

One graph, four different aisles

Four bottles, and between them roughly the price of a weekly shop every month. Vitamin D, fish oil, a probiotic, turmeric. You are taking some of them already or you are about to, and you would keep paying without hesitating if any of them worked, which is precisely the position the labels are written for and not a foolish position to be in. This piece ends with four questions that will settle most of that shelf for you in about a minute. It starts with why the answers keep coming out the same way.

Read the psoriasis supplement literature end to end and you stop seeing four separate stories. You see one story told four times. A plausible mechanism appears. Small trials follow, often with a few dozen participants and a few weeks of follow-up. Some are positive. Reviews pool them, the effect gets smaller or unstable, and the conclusion arrives with the word heterogeneous doing most of the work. Then a new formulation appears and the cycle restarts.

That is not a criticism of the researchers, who mostly say so themselves. It is a description of what happens when you take something that only ever existed as part of a whole diet, isolate it, and ask it to behave like a drug. A network meta-analysis assembling twenty-one randomised trials of dietary supplements as adjuncts in psoriasis is a good place to see the whole shape at once, including how modest the certainty attached to the individual signals is ^[9].

It also explains a puzzle that confuses a lot of readers. If eating a certain way has the better evidence, why does bottling its most famous nutrient not work? Because the nutrient was never established as the reason in the first place. That inference was made by marketers working backwards from a food pattern, not by anyone who tested it.

Sources for this section: [9] Effectiveness and safety of dietary supplements in the adjunctive treatment of psoriasis: a systematic review and network meta-analysis

Vitamin D: a real association doing no work

Start with the one that has the most convincing-sounding premise. People with psoriasis do, on average, have lower measured vitamin D levels than people without it, and that is a properly pooled observational finding rather than a rumour ^[4]. From there the reasoning seems to write itself. It does not.

Lower levels in a group can be produced by many things at once. Time spent indoors when your skin is bad, the disease itself, other health conditions, age, body composition, and simple confounding all pull in the same direction. The direction of causation is not established, and an association of this kind cannot tell you what will happen if you intervene. Only a trial can, and here trials exist.

They are not encouraging. A meta-analysis of randomised trials could not verify a robust favourable effect of oral vitamin D on psoriasis severity once the analysis was done carefully ^[2], and a second pooled analysis reached a similar place across the main assessment points ^[5]. The newer network analysis of supplements does report a vitamin D signal, which is a reason to keep the question open rather than to declare it answered ^[9]. Open is not the same as promising, and neither is the same as proven.

None of this touches the separate, ordinary medical question of whether you are actually deficient. If a clinician tests you and finds a deficiency, treating it is standard care with its own reasons, and those reasons do not need to involve your skin at all. What you cannot do is run that logic backwards and decide that eggs, fish or a fortified breakfast cereal are treating your psoriasis because of what they contain ^[4].

Sources for this section: [2] Effectiveness of oral vitamin D supplementation in lessening disease severity among patients with psoriasis: A systematic review and meta-analysis of randomized controlled trials · [4] Psoriasis and Vitamin D: A Systematic Review and Meta-Analysis · [5] Efficacy and safety of vitamin D supplementation on psoriasis: A systematic review and meta-analysis · [9] Effectiveness and safety of dietary supplements in the adjunctive treatment of psoriasis: a systematic review and network meta-analysis

Fish oil only looked useful when it was not working alone

Omega-3 is the most heavily marketed of the four and has the most interesting failure. A systematic review of fish oil in psoriasis found no effect on severity when it was used on its own, but signals when it was added to conventional treatment ^[1]. That is a genuinely informative negative, and it is almost never reported that way.

Think about what a result of that shape implies. Whatever is happening, it is not a substitute for treatment, it is at best something that might sit alongside one. Trials also differ enormously in dose, in the ratio of the two main omega-3 fatty acids, in duration and in who was enrolled, which is why later reviews attempting to convert this literature into dietary advice hedge as heavily as they do ^[3].

The jump people then make is the expensive one. Supplement doses in these trials are pharmacological. They are not what is in a piece of salmon, and a serving of fish is not a small dose of a drug that failed to work as monotherapy anyway. Fatty fish belongs in the eating pattern discussed elsewhere on this site because of the pattern, not because of a nutrient claim smuggled in through a supplement trial that did not even succeed on its own terms.

Sources for this section: [1] Efficacy of fish oil and its components in the management of psoriasis: a systematic review of 18 randomized controlled trials · [3] Evidence-based dietary recommendations for patients with psoriasis: A systematic review

Probiotics and curcumin: promising is not a dose

Probiotics are the most active of the four literatures and the most easily oversold. A meta-analysis of randomised trials of probiotics as an adjunct in psoriasis reports encouraging pooled results ^[6]. An umbrella review published since notes something important about that body of work: the reviews overlap substantially, drawing repeatedly on the same small pool of primary trials, which makes a field look larger and more replicated than it is ^[7].

Even taking the signal at face value, it cannot be acted on precisely. There is no identified strain, no established dose, no known duration and no product that has earned a recommendation for everyone with psoriasis. Microbiome studies in this population are heterogeneous, and while differences in gut bacteria are consistently described, causation remains unestablished, which matters enormously before anyone starts talking about resetting anything ^[8]. The leaky gut story you have been told as settled science is not settled at all.

Curcumin follows the same arc with an extra twist. The most cited positive trial used a nanoparticle curcumin formulation given alongside a conventional systemic medication, which is a long way from a jar of turmeric ^[10]. The pooled supplement analysis places curcumin among the compounds with limited, low-to-moderate certainty signals ^[9]. Culinary turmeric is a good spice. It is not that formulation, at that dose, alongside that drug, and no dinner inherits a trial result by containing an ingredient.

Across all four, the same boundary holds. These are adjunct questions at best, sitting beside prescribed treatment rather than replacing it, and none of them has produced something anyone can responsibly recommend to every reader.

Sources for this section: [6] The efficacy and safety of probiotics in the adjuvant treatment of psoriasis: a systematic review and meta-analysis of randomized controlled trials · [7] The Effectiveness of Probiotics in Psoriasis: An Umbrella Review · [8] Characterization of the Gut Microbiota in Patients with Psoriasis: A Systematic Review · [9] Effectiveness and safety of dietary supplements in the adjunctive treatment of psoriasis: a systematic review and network meta-analysis · [10] Curcumin nanoparticles potentiate therapeutic effectiveness of acitrein in moderate-to-severe psoriasis patients and control serum cholesterol levels

Four questions to ask the bottle before you pay for it

You do not need to read the literature yourself to avoid most of the damage. Four questions will filter nearly everything on the shelf, and you can ask them in the aisle with your phone in your hand.

First: was this tested against psoriasis severity, or against a laboratory marker? A change in a blood measurement is not a change in your skin, and marker studies are much cheaper to run and much easier to spin. Second: was it tested alone or added to treatment? If the evidence exists only as an add-on, then it can only ever be an add-on, and the fish oil literature makes that distinction plainly ^[1]. Third: is the tested form the thing being sold to you? Nanoparticle formulations, specific bacterial strains and pharmacological doses do not appear in supermarket products or in your cooking ^[10].

Fourth, and most important: how many people were in the trials, and did the effect survive being pooled with the others? This is the question that quietly kills most supplement claims, because the pattern in psoriasis is not a few clear wins but a lot of small studies whose combined signal is fragile and whose certainty is rated low ^[9]. A single positive trial in forty people is a reason for researchers to keep going. It is not a reason for you to set up a monthly direct debit.

If you already take something and want to continue, the sensible move is simply to tell your prescriber, because supplements interact with real medicines and that conversation is free. And if you were about to start something, consider what the same money buys as food across a month, where the evidence is thinner in the dermatology column but very much sturdier in the cardiovascular one.

One more reader deserves naming, because they are very often the person actually holding the bottle. A great many of these purchases are made by somebody else: a mother who wants to arrive with something in her hand, a partner who has run out of useful things to say after a bad month. Buying is what caring looks like when nothing else is on offer, and there is nothing ridiculous about the impulse. But what gets received is a daily reminder of being a problem somebody is working on, attached to a tablet nobody has justified. If you want to spend the money on them, spend it on the shopping, on the cooking, or on an afternoon where they do neither. Those are harder to wrap and they do not have to be believed in.

That is the whole argument, and it does not require you to buy anything. If the practical side is what you are missing in place of the reasoning, the companion psoriasis cookbook turns the eating pattern into a month of planned meals. It makes no claim any of these bottles failed to earn.

Sources for this section: [1] Efficacy of fish oil and its components in the management of psoriasis: a systematic review of 18 randomized controlled trials · [9] Effectiveness and safety of dietary supplements in the adjunctive treatment of psoriasis: a systematic review and network meta-analysis · [10] Curcumin nanoparticles potentiate therapeutic effectiveness of acitrein in moderate-to-severe psoriasis patients and control serum cholesterol levels